OncoSil Medical Limited (ASX:OSL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0040
0.00 (0.00%)
Apr 4, 2025, 3:36 PM AEST

OncoSil Medical Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Operating Revenue
0.890.520.370.230.21-
Upgrade
Other Revenue
1.021.051.10.831.092.76
Upgrade
Revenue
1.911.571.471.061.32.76
Upgrade
Revenue Growth (YoY)
47.09%6.68%38.00%-18.09%-53.02%-23.78%
Upgrade
Cost of Revenue
1.651.511.590.970.96-
Upgrade
Gross Profit
0.260.06-0.120.090.342.76
Upgrade
Selling, General & Admin
9.849.058.368.297.993.47
Upgrade
Research & Development
2.792.992.852.382.893.73
Upgrade
Operating Expenses
12.8512.0411.2110.6710.887.2
Upgrade
Operating Income
-12.59-11.98-11.34-10.58-10.54-4.43
Upgrade
Interest Expense
--0-0.01-0.02-0.02-0.03
Upgrade
Interest & Investment Income
0.060.070.060.010.080.1
Upgrade
Currency Exchange Gain (Loss)
-0.060.01-0.06-0.14-0.10
Upgrade
EBT Excluding Unusual Items
-12.6-11.91-11.34-10.73-10.58-4.35
Upgrade
Other Unusual Items
----0.150.09
Upgrade
Pretax Income
-12.6-11.91-11.34-10.73-10.43-4.26
Upgrade
Net Income
-12.6-11.91-11.34-10.73-10.43-4.26
Upgrade
Net Income to Common
-12.6-11.91-11.34-10.73-10.43-4.26
Upgrade
Shares Outstanding (Basic)
3,2192,2191,130811818656
Upgrade
Shares Outstanding (Diluted)
3,2192,2191,130811818656
Upgrade
Shares Change (YoY)
98.53%96.48%39.32%-0.89%24.68%4.40%
Upgrade
EPS (Basic)
-0.00-0.01-0.01-0.01-0.01-0.01
Upgrade
EPS (Diluted)
-0.00-0.01-0.01-0.01-0.01-0.01
Upgrade
Free Cash Flow
-12.84-11.02-11.37-10.12-8.87-4.48
Upgrade
Free Cash Flow Per Share
-0.00-0.01-0.01-0.01-0.01-0.01
Upgrade
Gross Margin
13.43%3.55%-8.27%8.55%25.98%100.00%
Upgrade
Operating Margin
-659.37%-765.58%-772.48%-994.72%-811.96%-160.34%
Upgrade
Profit Margin
-659.86%-761.07%-772.98%-1008.73%-803.61%-154.20%
Upgrade
Free Cash Flow Margin
-672.26%-704.07%-775.06%-951.30%-683.14%-161.98%
Upgrade
EBITDA
-12.59-11.98-11.32-10.55-10.51-4.4
Upgrade
EBITDA Margin
------159.38%
Upgrade
D&A For EBITDA
0.010.010.020.030.030.03
Upgrade
EBIT
-12.59-11.98-11.34-10.58-10.54-4.43
Upgrade
EBIT Margin
------160.34%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.